OverviewChartNewsTraderScreen

Insys Therapeutics Inc./  US45824V2097  /

Nasdaq Other OTC
2020-02-18  12:00:00 AM Chg. - Volume Bid- Ask- High Low
0.0420USD - 184,682
Turnover: -		 -Bid Size: - -Ask Size: - 0.0490 0.0390
GlobeNewswire 2021-10-07 Skye Bioscience Appoints Head of Regulatory Affairs & Quality Assurance and Senior Director of Resea...
GlobeNewswire 2021-10-07 Skye Bioscience Appoints Head of Regulatory Affairs & Quality Assurance and Senior Director of Resea...
GlobeNewswire 2021-05-20 CinCor Pharma Announces Appointments of Three Experienced Independent Members to Its Board of Direct...
GlobeNewswire 2020-06-23 Catalyst Pharmaceuticals Appoints Jeffrey Del Carmen as Chief Commercial Officer
GlobeNewswire 2019-07-03 FDA Accepts New Drug Application for INSYS Therapeutics’ Naloxone Nasal Spray for the Emergency Trea...
GlobeNewswire 2019-06-21 Delisting of Securities of FTD Companies, Inc., Kaixin Auto Holdings (Warrant Only), CytRx Corporati...
GlobeNewswire 2019-06-12 INSYS Therapeutics, Inc. Receives Court Approval of “First Day” Motions
TeleTrader 2019-06-10 Insys files for bankruptcy after settling bribe charges
GlobeNewswire 2019-06-10 INSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy L...
GlobeNewswire 2019-05-11 INSYS Therapeutics Reports First Quarter 2019 Results
GlobeNewswire 2019-04-15 INSYS Therapeutics Implements Leadership Changes
GlobeNewswire 2019-04-10 Global Medical Cannabis Market 2014-2018 & 2019-2024 by Product Type, Application, Consumption Patte...
GlobeNewswire 2019-04-08 Report: Exploring Fundamental Drivers Behind Zscaler, Golden Star Resources, Flexion Therapeutics, S...
GlobeNewswire 2019-03-25 INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray at The C...
GlobeNewswire 2019-03-20 Global Opioid Use Disorder (OUD) Opportunity Analysis and Forecasts 2018-2027: Experienced and New P...
GlobeNewswire 2019-03-07 INSYS Therapeutics Reports Fourth Quarter and Full Year 2018 Results
GlobeNewswire 2019-03-06 INSYS Therapeutics to Report Fourth Quarter and Full Year 2018 Results on March 7
GlobeNewswire 2019-02-25 INSYS Therapeutics Presented Poster of Initial Pharmacokinetic Study of Epinephrine Nasal Spray for ...
GlobeNewswire 2019-01-09 INSYS Therapeutics Announces Results of Dose-Finding PK Study for Epinephrine Nasal Spray for Treatm...
GlobeNewswire 2019-01-03 INSYS Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 2018-12-18 INSYS Therapeutics Announces Participation at FDA Advisory Committee Meeting Addressing the Co-Presc...
GlobeNewswire 2018-12-17 INSYS Therapeutics Provides Update on Strategic Alterative Review Process and Product Pipeline Spann...
GlobeNewswire 2018-12-06 Montgomery County Joins the Fight Against the Opioid Industry:
GlobeNewswire 2018-12-06 Detailed Research: Economic Perspectives on AT&T, JD, EMC Insurance Group, Insys Therapeutics, Medid...
GlobeNewswire 2018-12-04 INSYS Therapeutics Presents New Clinical Data from Long-Term Safety Study of CBD Oral Solution in R...